recognize the irAEs associated with ICI treatment
support patients undergoing ICI treatment
provide prompt referral for specialist care when appropriate
Immune checkpoint inhibitors help the immune system to destroy cancer cells. This type of immunotherapy works differently from chemotherapy and causes different kinds of side effects, called immune-related adverse events.
Bernardo L Rapoport MD
Specialist Physician and Medical Oncologist-in-Charge, The Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg; and Department of Immunology, Faculty of Health Sciences, University of Pretoria, South Africa
Helen Westman RN MN (Oncology)
Lung Cancer Nurse Coordinator, Cancer and Palliative Care Network; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia
On successful completion of this course South African registered medical professionals (HPCSA) are able to receive 1 CPD point - Level 1 Clinical.
Course accreditation number: MDB015/121/01/2022
An independent program provided as a service to medicine by MSDMSD (Pty) Ltd (Reg. No. 1996/003791/07) 117-16th Road, Private Bag 3, Halfway House, 1685, South Africa. Tel: +27(0)11655-3000. www.msd.co.za. Copyright ©2021. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved. ZA-KEY-00312. Exp. Date: 28/05/2023